Pilar Navarro

13PUBLICATIONS
71CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 08, 2026
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

|Mar 31, 2025
Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysis.

Soraya Hernández-Hatibi, Carlos Borau, Neus Martínez-Bosch

|Mar 29, 2023
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.

Neus Martínez-Bosch, Noelia Vilariño, Francesc Alameda

|Feb 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol

|Dec 23, 2022
Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice.

Laura Miró, Júlia López, Pedro E Guerrero

|Feb 25, 2022
Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells.

Aleyda Benitez-Amaro, Neus Martínez-Bosch, Noemí Manero-Rupérez

Pageof 3

Frequent Collaborators

6 joint publications

Neus Martínez-Bosch

2 joint publications

Pedro Enrique Guerrero

2 joint publications

Laura Miró

2 joint publications

Esther Llop